Sphenopalatine Ganglion Block for Post-Dural Puncture Headache in Orthopedic Patients

Tanta University

Status and phase: Unknown; Phase 4

Conditions: Orthopedic; Adrenaline; Sphenopalatine Ganglion Block; Randomized Controlled Study; Post-Dural Puncture Headache

Treatments: Procedure: Sphenopalatine Ganglion Block; Drug: Medical Treatment

Study type: Interventional

Funder types: Other

Identifiers

NCT04657952

34268/11/20

Details and patient eligibility

About

The aim of this study is to assess the efficacy, onset and duration of analgesia of sphenopalatine ganglion bock (SPGB) using lidocaine 4% with adrenaline as a treatment of postoperative Post dural puncture headache (PDPH) of orthopedic patients after lower limbs surgeries.

Enrollment: 60 estimated patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Admitted to the orthopedic department
• Complaining of criteria of severe post-dural puncture headache within 7 days following subarachnoid block used for lower limbs surgeries.
• American Society of Anesthesiologists (ASA) physical status I and II.

Exclusion criteria

• Patient refusal or uncooperative.
• Patients with uncontrollable hypertension.
• Patient with known coagulopathy.
• Patient with nasal septal deviation, polyp, history of nasal bleeding.
• Patient with allergy to local anesthetics
• American Society of Anesthesiologists physical status>2.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

60 participants in 2 patient groups

Standard medical Treatment (paracetamol)

Active Comparator group

Description:

Patients will receive paracetamol 1 gm every 6 hours daily intravenously for a day.

Treatment:

Drug: Medical Treatment

Sphenopalatine block

Experimental group

Description:

Patients will receive sphenopalatine block

Treatment:

Procedure: Sphenopalatine Ganglion Block